Transdermal Drug Delivery System Market - Top Companies and Manufacturers

Companies Dominating the Transdermal Drug Delivery System Landscape

Key companies in the transdermal drug delivery systems market are driving innovation through advancements in technologies such as microneedles, iontophoresis, and smart patches. These advancements are revolutionizing how drugs are delivered, offering improved absorption efficiency and better patch adhesion while expanding the range of drugs that can be administered transdermally. A notable example is Adlarity, a transdermal patch for Alzheimer’s disease launched by Corium Inc. in September 202. These innovations are making transdermal systems more effective, versatile, and accessible to patients worldwide These key players include:

Novartis AG
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis

Johnson & Johnson
Mylan Pharmaceuticals, Inc.
Boehringer Ingelheim GmbH
3M Company
Noven Pharmaceuticals, Inc.
4P Therapeutics, LLC
Grünenthal
AbbVie

Browse Key Market Insights with Data Illustration:

Transdermal Drug Delivery System Market Size Report 2037

In the News

In March 2023, bioNxt Solution Inc. declared that it has signed a contract to conduct comparative drug absorption research for the company's transdermal (TDS) rotigotine patch, which is used to treat Parkinson's disorders.

IIn February 2023, Twirla (levonorgestrel and ethyl estradiol) transdermal drug delivery devices, a novel non-daily, non-invasive contraceptive patch, was commercially introduced in the U.S. by Agile Therapeutics, Inc.

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of the transdermal drug delivery system market was over USD 74.6 billion.

The market size for the transdermal drug delivery system market is projected to reach USD 296.9 billion by the end of 2037 expanding at a CAGR of 12.2% during the forecast period i.e., between 2025-2037.

The major players in the market are Johnson & Johnson, Mylan Pharmaceuticals, Inc., Boehringer Ingelheim GmbH, 3M Company, and others.

In terms of technology, the iontophoresis segment is anticipated to garner the largest market share by 2037 and display lucrative growth opportunities during 2025-2037.

The market in North America is projected to hold the largest market share of 47.6 % by the end of 2037 and provide more business opportunities in the future.

Transdermal Drug Delivery System Market - Top Companies and Manufacturers

Companies Dominating the Transdermal Drug Delivery System Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How big is the transdermal drug delivery system market?

What is the outlook for the transdermal drug delivery system market?

Who are the major players dominating the transdermal drug delivery system market?

Which technology segment will capture the significant market share for the transdermal drug delivery system market by 2037?

Which region will provide more business opportunities for the growth of the transdermal drug delivery system market in the future?